Wednesday, December 01, 2021

NEWS

Gamaleya director claims Sputnik Light reduces contagion

Gamaleya director claims Sputnik Light reduces contagion

Moscow, Apr 4 (Prensa Latina) The use of Russia's Sputnik Light vaccine halves the risk of contagion with the SARS CoV-2 coronavirus, which causes Covid-19, Alexander Gintsburg, director of the Gamaleya Epidemiology and Microbiology Center, claimed on Sunday.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The scientist told Russia 1 channel that if the ‘Light option’ is used, Sputnik V vaccine’s first component, without the second dose, ‘it is possible to reduce the disease by 50 percent, or even 60 percent,’ he said.

On March 29, the Ministry of Health of the Russian Federation registered the Sputnik Light drug against Covid-19 and, previously, on Feb.27, started immunization of those who took part in the study of the vaccine in Moscow.

Earlier, Gintsburg had declared that this vaccine will allow for the reduction of serious and fatal cases caused by the disease, but in no way we can say that it will replace Sputnik V.

The head of the team that produced Sputnik Light explained that the drug protects people during four to five months and aims at eliminating Sputnik V’s main problem: the presence of two components administered to a patient with a time span of 21 days.

mh/aph/jha/mml

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.